Clinical research is the branch of medical science that studies health, disease, and medical interventions in human participants. It is the mechanism by which a laboratory observation becomes a treatment that a physician can prescribe with confidence, and the mechanism by which an existing treatment can be shown to work less well than assumed. Every approved medicine, vaccine, diagnostic test, and surgical technique in routine use today rests on a body of clinical research.

This guide explains what clinical research is, how it differs from other forms of medical science, the main study designs and what each can and cannot demonstrate, how research is regulated and reviewed, and how findings move from a completed study into clinical practice.

What Is Clinical Research?

Clinical research is scientific investigation involving human participants that is designed to answer questions about health and disease. It includes studies of how diseases arise and progress, how they are detected, how they can be prevented or treated, and how health services can be delivered more effectively.

Two features distinguish clinical research from other kinds of medical enquiry. First, the subjects are people, which brings ethical obligations that do not apply to laboratory work. Second, the aim is to produce generalizable knowledge rather than to care for one individual. A physician adjusting a dose for a particular patient is practising medicine; an investigator comparing two doses in a defined population according to a written protocol is conducting research.

Clinical Research and Preclinical Research

Preclinical research takes place before human testing. It includes work in cell cultures, tissue models, computational systems, and animal models, and it is used to explore biological mechanisms and to assess whether a candidate intervention is plausible and sufficiently safe to justify a first human study. Preclinical promise frequently does not translate: many compounds that appear effective in animal models fail in human trials, which is a central reason clinical research is indispensable rather than confirmatory.

Clinical Research and Clinical Trials

The terms are often used interchangeably, but a clinical trial is a subset of clinical research. A clinical trial is an interventional study in which participants are assigned to receive a specific intervention according to a protocol. Clinical research is the wider category, also encompassing observational cohorts, case-control studies, registries, diagnostic accuracy studies, health services research, and analyses of existing health data.

The Main Types of Clinical Research

Study design determines what a study can legitimately claim. The most consequential distinction is whether investigators assign the exposure or intervention.

Interventional Studies

In an interventional study, investigators allocate participants to an intervention — a drug, a device, a procedure, a behavioural programme, or a comparator such as standard care or placebo — and then measure predefined outcomes. Because allocation is controlled and, in the strongest designs, randomized, interventional studies can support causal conclusions.

Observational Studies

In an observational study, investigators record what happens without assigning treatment. Common forms include:

  • Cohort studies, which follow defined groups over time and compare outcomes between those with and without a given exposure.
  • Case-control studies, which start from people who have an outcome and look backwards at prior exposures, an efficient design for rare conditions.
  • Cross-sectional studies, which measure exposure and outcome at a single point in time and are well suited to estimating prevalence.
  • Registries and real-world data analyses, which use routinely collected clinical records, claims, or disease registries to study large populations under everyday conditions.

Observational designs are subject to confounding: an apparent association between an exposure and an outcome may be produced by a third factor related to both. Statistical adjustment reduces but does not eliminate this problem, which is why observational findings are usually described as associations rather than causes.

Diagnostic and Prognostic Studies

Not all clinical research evaluates treatment. Diagnostic accuracy studies assess how well a test identifies the presence or absence of a condition, typically reporting sensitivity, specificity, and predictive values against a reference standard. Prognostic studies examine which characteristics predict the future course of a condition. Both underpin screening programmes and clinical decision rules.

Evidence Synthesis

Systematic reviews identify and appraise all studies addressing a defined question according to a prespecified method. Meta-analyses statistically combine compatible results to produce a pooled estimate. Well-conducted syntheses sit at the top of most evidence hierarchies because they reduce the influence of any single study, though their reliability depends entirely on the quality and completeness of the studies included.

How a Clinical Study Is Designed and Conducted

Rigorous clinical research follows a sequence intended to protect participants and to prevent results from being shaped after the fact.

The Research Question and Protocol

A study begins with a specific, answerable question and a protocol: a written document specifying the objectives, eligibility criteria, intervention and comparator, outcome measures, sample size calculation, statistical analysis plan, and safety monitoring arrangements. The protocol is written before enrolment begins. Prespecifying the primary outcome is essential, because analysing many outcomes and reporting the most favourable one produces findings that are unlikely to replicate.

Ethical and Regulatory Review

Before recruitment, the protocol is reviewed by an independent ethics committee — known in the United States as an institutional review board — which assesses the balance of risk and benefit, the adequacy of consent procedures, and the protection of participants who may be vulnerable. Studies of investigational medicines or devices additionally require authorization from the relevant regulator, such as the U.S. Food and Drug Administration or a national competent authority operating within the European Union framework overseen by the European Medicines Agency.

Registration and Transparency

Studies are registered in public registries such as ClinicalTrials.gov or registries feeding the WHO International Clinical Trials Registry Platform. Registration records the design and planned outcomes before results are known, making it possible to detect unreported studies and outcome switching. Many journals require prospective registration as a condition of publication.

Informed Consent

Participation must be voluntary and informed. Prospective participants receive an explanation of the purpose, procedures, foreseeable risks, potential benefits, alternatives, and their right to withdraw at any time without penalty to their care. Consent is a continuing process rather than a single signature, and additional safeguards apply where participants cannot consent for themselves.

Conduct, Monitoring, and Data Integrity

Studies are conducted under Good Clinical Practice, an international quality standard covering design, conduct, recording, and reporting. Adverse events are recorded and reported according to defined timelines. Larger trials often appoint an independent data monitoring committee that reviews accumulating safety and efficacy data and can recommend stopping a trial early for harm, for clear benefit, or for futility.

Analysis and Reporting

Analysis follows the prespecified plan. Interventional trials commonly use intention-to-treat analysis, in which participants are analysed in the group to which they were assigned regardless of what they subsequently received, preserving the benefit of randomization. Results are reported with measures of uncertainty, typically confidence intervals, and are increasingly expected to be posted to the registry as well as published, whether or not the findings are positive.

Who Conducts and Funds Clinical Research?

Clinical research is carried out by academic medical centres, hospitals, universities, government research institutes, pharmaceutical and biotechnology companies, medical device manufacturers, and contract research organizations working on sponsors' behalf. Funding comes from public bodies such as the National Institutes of Health and national research agencies, from charitable and philanthropic foundations, and from industry.

Funding source does not by itself determine validity, but it is material information. Financial and non-financial interests are disclosed in publications and registry records so that readers can weigh them alongside the design and conduct of the study.

From Research Findings to Clinical Practice

A completed study does not immediately change practice. Findings are typically submitted for peer review and publication, where independent experts assess methods and interpretation. Regulators evaluate submitted evidence when deciding whether to authorize a product and on what terms. Professional bodies and guideline developers appraise the accumulated evidence and issue recommendations, usually grading the strength of each recommendation and the certainty of the underlying evidence.

Even then, adoption is uneven. The gap between evidence and routine practice is itself a field of study — implementation science — concerned with why effective interventions are underused and how uptake can be improved. Meanwhile, post-marketing surveillance and pharmacovigilance continue to monitor safety after approval, because rare adverse effects may only become detectable once a product is used in far larger and more varied populations than any trial can enrol.

Common Limitations to Keep in Mind

  • Generalizability. Trial populations are often younger, healthier, and less diverse than the patients who will eventually receive the treatment. Results may not transfer directly.
  • Surrogate outcomes. Trials sometimes measure a laboratory marker rather than an outcome that matters to patients. Improvement in a marker does not guarantee improvement in survival or quality of life.
  • Statistical significance. A significant result indicates that an observed difference is unlikely under the assumption of no effect; it says nothing about whether the difference is large enough to matter clinically.
  • Publication bias. Studies with positive findings have historically been more likely to be published, which can distort the apparent weight of evidence. Registration and results-posting requirements are intended to counter this.
  • Single studies. Replication by independent teams remains the strongest safeguard against error.

Sources

  • World Health Organization — clinical trials and research standards; International Clinical Trials Registry Platform
  • U.S. National Institutes of Health — definitions of clinical research and clinical trials
  • ClinicalTrials.gov — trial registration and results reporting
  • U.S. Food and Drug Administration — regulation of clinical investigations
  • European Medicines Agency — clinical trial regulation and Good Clinical Practice guidance
  • World Medical Association — Declaration of Helsinki
  • International Council for Harmonisation — Good Clinical Practice guideline